Related Experiment Video
Updated: Jun 27, 2026
In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Epigenetic inactivation of SLIT2 in human hepatocellular carcinomas
1Institute of Life Sciences, Jiangsu University, Zhenjiang, China.
Abstract:
Recent findings have shown that SLIT2 appears to function as a novel tumor suppressor gene. In addition, hypermethylation of its promoter region has been detected in various cancers, including breast and lung cancer, colorectal carcinoma, and gliomas. Here, we report for the first time that there is epigenetic silencing of SLIT2 in human hepatocellular carcinoma (HCC). Downregulation of SLIT2 was detected in 6 of 8 (75%) HCC cell lines by quantitative real-time RT-PCR (qRT-PCR), and the downregulation of SLIT2 was generally dependent on the degree of methylation at the promoter region. Furthermore, expression of SLIT2 was restored in relatively low-expressing cell lines after treatment with 5-aza-2-deoxycytidine (5-Aza-dC). Downregulation of SLIT2 expression was also detected in 45 of 54 primary HCC samples (83.3%), and the decrease in expression was significantly correlated with CpG island hypermethylation. This decrease of SLIT2 expression was also associated with lymph node metastasis in HCC. Moreover, overexpression of SLIT2 in SMMC-7721 cells induced by recombinant adenovirus suppressed cell growth, migration, and invasion, These results suggest that epigenetic inactivation of SLIT2 in HCC may be important in the development and progression of HCC. Thus, SLIT2 may be useful as a therapeutic target in the treatment of HCC.
Insights
Epigenetic silencing of SLIT2, a tumor suppressor, is observed in hepatocellular carcinoma (HCC). Its downregulation correlates with hypermethylation and impacts HCC progression, suggesting SLIT2 as a therapeutic target.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- SLIT2 functions as a tumor suppressor gene.
- Hypermethylation of SLIT2 promoter is implicated in various cancers.
- Epigenetic silencing of SLIT2 in hepatocellular carcinoma (HCC) was previously uncharacterized.
Purpose of the Study:
- To investigate the role of SLIT2 epigenetic silencing in human HCC.
- To determine the correlation between SLIT2 expression, promoter methylation, and HCC progression.
- To evaluate SLIT2 as a potential therapeutic target for HCC.
Main Methods:
- Quantitative real-time RT-PCR (qRT-PCR) to assess SLIT2 expression in HCC cell lines and primary samples.
- Analysis of SLIT2 promoter methylation status.
- Treatment of HCC cell lines with 5-aza-2-deoxycytidine (5-Aza-dC) to evaluate gene expression restoration.
- Overexpression of SLIT2 using recombinant adenovirus in HCC cells to assess functional impact.
- Correlation analysis between SLIT2 expression, methylation, and clinical parameters like lymph node metastasis.
Main Results:
- SLIT2 downregulation was detected in 75% of HCC cell lines and 83.3% of primary HCC samples.
- Decreased SLIT2 expression significantly correlated with CpG island hypermethylation at its promoter region.
- SLIT2 expression was restored upon treatment with 5-Aza-dC, indicating epigenetic regulation.
- Reduced SLIT2 expression was associated with lymph node metastasis in HCC patients.
- Overexpression of SLIT2 suppressed HCC cell growth, migration, and invasion.
Conclusions:
- Epigenetic inactivation of SLIT2 is a frequent event in HCC.
- SLIT2 downregulation, driven by promoter hypermethylation, contributes to HCC development and progression.
- SLIT2 holds potential as a therapeutic target for hepatocellular carcinoma.
Related Concept Videos
02:30Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:37Epigenetic Regulation
X-chromosome...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
03:17Inheritance of Chromatin Structures